1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2025Impact of medical crisis on the critical care system in South KoreaACUTE AND CRITICAL CARE
2025Bridging the Gap in Elimination of Hepatitis C Virus among People Who Use Drugs in South Korea GUT AND LIVER
2025Pharmaco-economic Inequalities in Access to Antifibrotic Treatment for Interstitial Lung Disease in the Asia-Pacific Region TUBERCULOSIS AND RESPIRATORY DISEASES
2025Oral Branched-Chain Amino Acids as a Cost-Effective Option for Managing Hepatic Encephalopathy YONSEI MEDICAL JOURNAL
2025Expert survey on systemic therapy indications for hepatocellular carcinoma in Korea: bridging clinical practice and reimbursement criteria Journal of Liver Cancer(대한간암학회지)
2025Serum Phosphorus Is a Fast and Highly Sensitive Marker Predictive of a Complete Cure of Tumor-Induced Osteomalacia JOURNAL OF CLINICAL MEDICINE
2025Rethinking adjunctive dobutamine in septic shock: time to individualize, not generalize KOREAN JOURNAL OF INTERNAL MEDICINE
2025Initial Pharmacological Strategies in People with Early Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis DIABETES & METABOLISM JOURNAL
2025Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes DIABETES & METABOLISM JOURNAL
2025BOS172738, a selective RET inhibitor, for the treatment of patients with RET-altered tumors including RET-fusion-positive non-small-cell lung cancer and RET-mutant medullary thyroid cancer: a phase I dose-escalation/expansion multicenter study ESMO OPEN
2025LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti–Programmed Cell Death Protein 1 or Anti–Programmed Cell Death Ligand 1 Plus Platinum Chemotherapy JOURNAL OF THORACIC ONCOLOGY
2025Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 JTO Clinical and Research Reports
2025Durvalumab With or Without Tremelimumab in Combination With Chemoradiotherapy in Patients With Limited-Stage SCLC: Results from the Phase 1 CLOVER Study JTO Clinical and Research Reports
2025Impact of COVID-19 therapeutics on the development of post-infectious lung fibrosis FRONTIERS IN MICROBIOLOGY
2025Elevated IL-6 levels in the intestinal mucosa of patients with gastrointestinal Behçet’s disease INTESTINAL RESEARCH
2025Nationwide coverage of molecular drug susceptibility testing in patients with pulmonary multidrug/rifampicin-resistant tuberculosis in South Korea: a retrospective cohort study (2015–2021) BMJ OPEN RESPIRATORY RESEARCH
2025Real-World Use of carfilzomib-lenalidomide-dexamethasone (KRd) and carfilzomib-dexamethasone (Kd) in Relapsed/Refractory Multiple Myeloma in the Asia Pacific Region: A Prospective Multicenter Observational Study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2025Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum CANCERS
2025Conventional machine learning-based prediction models did not outperform the International IgA Nephropathy Prediction Tool KIDNEY RESEARCH AND CLINICAL PRACTICE
2025Optimal time and volume of fluid resuscitation in patients with sepsis: a nationwide multicenter cohort study SCIENTIFIC REPORTS

Recent Submissions

Browse

Links